Behavioral
Springfield Treatment Center
Springfield Treatment Center was paid $20.46M by Medicaid between Apr 2018 and Dec 2024, across 23 billing codes. Its largest line is S0109, Methadone, oral, 5 mg — 75% of everything it billed.
33Billing provider infoSPRINGFIELD TREATMENT CENTER
SPRINGFIELD, OR 97477
SPRINGFIELD, OR 97477
33aNPI1710498001assigned 10/13/2017
33bProvider typeAddiction (Substance Use Disorder) Counselor
28Total paid$20.46M
24GClaims249,547
24DCodes billed23
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers
Next to other Addiction (Substance Use Disorder) Counselor providers in Oregon
Rank by total paid#3 of 99
Median peer was paid$85K
This provider vs. median240×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,924 | $765K | |
| 2019 | 41,004 | $3.57M | |
| 2020 | 35,485 | $3.14M | |
| 2021 | 40,700 | $3.29M | |
| 2022 | 37,380 | $2.95M | |
| 2023 | 31,626 | $2.90M | |
| 2024incomplete | 45,428 | $3.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S0109 | Methadone, oral, 5 mg | 75% | 72,891 | 14,911 | $15.29M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 7.9% | 84,982 | 16,436 | $1.62M |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 6.0% | 14,389 | 8,331 | $1.22M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 4.5% | 20,321 | 12,812 | $930K |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 1.5% | 22,444 | 14,395 | $313K |
| H0001 | Alcohol and/or drug assessment | 1.3% | 1,541 | 1,445 | $257K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | <1% | 2,631 | 498 | $186K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 3,467 | 1,393 | $167K |
| H0006 | Alcohol and/or drug services; case management | <1% | 5,731 | 3,157 | $107K |
| H0032 | Mental health service plan development by non-physician | <1% | 761 | 730 | $90K |
| H0033 | Oral medication administration, direct observation | <1% | 5,242 | 973 | $85K |
| 80305 | <1% | 8,034 | 5,507 | $67K |
11 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,401 | $45K |
| J3490 | Unclassified drugs | <1% | 1,113 | $42K |
| 93000 | <1% | 1,346 | $15K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 339 | $14K |
| 86580 | <1% | 918 | $6K | |
| 81025 | <1% | 564 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 69 | $3K |
| 84702 | <1% | 223 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 50 | $1K |
| 98966 | <1% | 62 | $656.97 | |
| G1028 | Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOWEN, MATTHEW (AUTHORIZED OFFICIAL)
Parent organizationORTC LLC
| Provider | Location | Paid |
|---|---|---|
| Utica Township Volunteer Fire Fighters Association | Jeffersonville, IN | $4.91M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.